Literature DB >> 20424932

Recent advances in iron metabolism and related disorders.

Clara Camaschella1, Paolo Strati.   

Abstract

Iron is essential for life, because it is indispensable for several biological reactions such as oxygen transport, DNA synthesis and cell proliferation, but is toxic if present in excess since it causes cellular damage through free radical formation. Either cellular or systemic iron regulation can be disrupted in disorders of iron metabolism. In the past few years, our understanding of iron metabolism and its regulation has dramatically changed. New disorders of iron metabolism have emerged and the role of iron has started to be recognized as a cofactor of other disorders. The study of genetic conditions such as hemochromatosis and iron-refractory-iron-deficiency anemia (IRIDA) has provided crucial insights into the molecular mechanisms controlling iron homeostasis. In the future, these advances may be exploited for a more effective treatment of both genetic and acquired iron disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424932     DOI: 10.1007/s11739-010-0387-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  49 in total

Review 1.  Role of iron in neurodegenerative disorders.

Authors:  Daniela Berg; Moussa B H Youdim
Journal:  Top Magn Reson Imaging       Date:  2006-02

2.  Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.

Authors:  Emanuele Angelucci; Giovanni Barosi; Clara Camaschella; Maria Domenica Cappellini; Mario Cazzola; Renzo Galanello; Monia Marchetti; Antonio Piga; Sante Tura
Journal:  Haematologica       Date:  2008-04-15       Impact factor: 9.941

Review 3.  The neurological presentation of ceruloplasmin gene mutations.

Authors:  Alisdair McNeill; Massimo Pandolfo; Jens Kuhn; Huifang Shang; Hiroaki Miyajima
Journal:  Eur Neurol       Date:  2008-07-30       Impact factor: 1.710

Review 4.  Mutations in the gene encoding DMT1: clinical presentation and treatment.

Authors:  Achille Iolascon; Luigia De Falco
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 5.  Hereditary causes of disturbed iron homeostasis in the central nervous system.

Authors:  Prem Ponka
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 6.  Iron sequestration and anemia of inflammation.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 7.  Iron in arterial plaque: modifiable risk factor for atherosclerosis.

Authors:  Jerome L Sullivan
Journal:  Biochim Biophys Acta       Date:  2008-06-19

8.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

9.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  7 in total

1.  Iron replacement in inflammatory bowel diseases: an evolving scenario.

Authors:  Fabiana Busti; Giacomo Marchi; Domenico Girelli
Journal:  Intern Emerg Med       Date:  2019-02-05       Impact factor: 3.397

2.  TfR1 Extensively Regulates the Expression of Genes Associated with Ion Transport and Immunity.

Authors:  Nan Huang; Lei-Lei Zhan; Yi Cheng; Xiao-Long Wang; Ya-Xun Wei; Qi Wang; Wen-Jing Li
Journal:  Curr Med Sci       Date:  2020-07-17

3.  Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency?

Authors:  Ewa Uscinska; Bozena Sobkowicz; Robert Sawicki; Izabela Kiluk; Malgorzata Baranicz; Tomasz Stepek; Milena Dabrowska; Maciej Szmitkowski; Wlodzimierz J Musial; Agnieszka M Tycinska
Journal:  Intern Emerg Med       Date:  2014-12-13       Impact factor: 3.397

4.  Clinical significance of microcytosis in patients with primary myelofibrosis.

Authors:  Paolo Strati; Naveen Pemmaraju; Zeev Estrov; Marylou Cardenas-Turanzas; Sherry Pierce; Kate J Newberry; Naval Daver; Jorge Cortes; Hagop Kantarjian; Srdan Verstovsek
Journal:  Leuk Res       Date:  2014-08-28       Impact factor: 3.156

Review 5.  Iron metabolism: from health to disease.

Authors:  Fernando Oliveira; Sara Rocha; Rúben Fernandes
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

6.  Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.

Authors:  Nan Huang; Yaxun Wei; Yi Cheng; Xiaolong Wang; Qi Wang; Dong Chen; Wenjing Li
Journal:  Genes Genomics       Date:  2022-01-23       Impact factor: 1.839

7.  Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.

Authors:  Simon D Roger; Carlo A Gaillard; Andreas H Bock; Fernando Carrera; Kai-Uwe Eckardt; David B Van Wyck; Maureen Cronin; Yvonne Meier; Sylvain Larroque; Iain C Macdougall
Journal:  Nephrol Dial Transplant       Date:  2017-09-01       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.